Response to 'Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort by Ruyssen-Witrand et al

We would like to thank Ruyssen-Witrand et al for their interest in our study1 and their data from French patients with rheumatoid arthritis collected during the first wave of the COVID-19 pandemic through an online survey.2 Despite the fact that up to 70% of medical consultations could not be performed as planned due to confinement, adherence to immunosuppressive medication was very high (>80%), confirming our findings in Switzerland. This is all the more remarkable, as confinement measures were more stringent in France than in Switzerland. The rapid switch from physical visits to remote ways of patient–physician interaction, as also documented in their analysis, most probably led to these encouraging results.

Ethics statementsPatient consent for publication

留言 (0)

沒有登入
gif